Collegium Pharmaceutical Inc
NASDAQ:COLL

Watchlist Manager
Collegium Pharmaceutical Inc Logo
Collegium Pharmaceutical Inc
NASDAQ:COLL
Watchlist
Price: 48.36 USD -1.02% Market Closed
Market Cap: 1.5B USD

Intrinsic Value

The intrinsic value of one COLL stock under the Base Case scenario is 64.95 USD. Compared to the current market price of 48.36 USD, Collegium Pharmaceutical Inc is Undervalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

COLL Intrinsic Value
64.95 USD
Undervaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Collegium Pharmaceutical Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about COLL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is COLL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Collegium Pharmaceutical Inc.

Explain Valuation
Compare COLL to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about COLL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Collegium Pharmaceutical Inc

Current Assets 613.9m
Cash & Short-Term Investments 285.9m
Receivables 233.9m
Other Current Assets 94.1m
Non-Current Assets 993.5m
PP&E 16.7m
Intangibles 870.9m
Other Non-Current Assets 105.9m
Current Liabilities 452.9m
Accounts Payable 7.6m
Accrued Liabilities 355.6m
Other Current Liabilities 89.7m
Non-Current Liabilities 879.6m
Long-Term Debt 743.5m
Other Non-Current Liabilities 136.1m
Efficiency

Free Cash Flow Analysis
Collegium Pharmaceutical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Collegium Pharmaceutical Inc

Revenue
757.1m USD
Cost of Revenue
-323.9m USD
Gross Profit
433.2m USD
Operating Expenses
-276.2m USD
Operating Income
157m USD
Other Expenses
-98.5m USD
Net Income
58.4m USD
Fundamental Scores

COLL Profitability Score
Profitability Due Diligence

Collegium Pharmaceutical Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive ROE
Exceptional Gross Margin
Positive 3Y Average ROE
59/100
Profitability
Score

Collegium Pharmaceutical Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

COLL Solvency Score
Solvency Due Diligence

Collegium Pharmaceutical Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
High D/E
30/100
Solvency
Score

Collegium Pharmaceutical Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

COLL Price Targets Summary
Collegium Pharmaceutical Inc

Wall Street analysts forecast COLL stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COLL is 47.74 USD with a low forecast of 44.44 USD and a high forecast of 50.4 USD.

Lowest
Price Target
44.44 USD
8% Downside
Average
Price Target
47.74 USD
1% Downside
Highest
Price Target
50.4 USD
4% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Collegium Pharmaceutical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for COLL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

COLL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one COLL stock?

The intrinsic value of one COLL stock under the Base Case scenario is 64.95 USD.

Is COLL stock undervalued or overvalued?

Compared to the current market price of 48.36 USD, Collegium Pharmaceutical Inc is Undervalued by 26%.

Back to Top